- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 16, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece posted on MobiHealthNews cited an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Diabetic Amputations May Be Rising in the United States,” examined a study published in Diabetes Care that found lower-limb amputations may be rising in the United States after decades of decline. This comes amid reports of rising rates of diabetes and obesity among young adults and soaring insulin costs, which may mean diabetes is not being effectively treated. The article was additionally referenced by Yahoo Finance.
An article by Voice of America, titled “College Revenues Shrinking During Coronavirus Pandemic,” cited an interview published on AJMC.com. The interview, “How Have Colleges, Universities Addressed the COVID-19 Pandemic?,” featured Dennis Scanlon, PhD, distinguished professor of Health Policy and Administration at Pennsylvania State University, who spoke on the myriad of factors considered by colleges and universities when deciding how to reopen amid the coronavirus disease 2019 pandemic, particularly in prioritizing the safety of students, faculty, and community members, as well as the quality of education delivered.
FDA Approves bluebird bio's Lovo-Cel Gene Therapy for Sickle Cell Disease
December 10th 2023The decision was supported by efficacy data from 36 patients from the ongoing phase 1/2 HGB-206 trial (NCT02140554) and 2 patients in the phase 3 HGB-210 trial (NCT04293185). It was the second approval from FDA for a gene therapy for sickle cell disease.
Read More
Cellular Therapies in Lymphoma Bring Hope, but Optimizing Their Use Remains a Challenge
December 10th 2023Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.
Read More
